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SUMMARY
The commonly recommended treatment for ampullary tumours - pancreaticoduodenectomy
results in significant morbidity and mortality. This study is a retrospective evaluation of the
procedure of transduodenal local excision of ampullary tumours. Demographics, symptoms,
histologicalfindingsandoutcomes wereretrospectively analysed in 15 patients. Survivalanalysis
was done by the method of Kaplan-Meier and log-rank test.
Themedianagewas68years (range 54-78). Endoscopic biopsy was accurate in only 41% ofcases.
CT scan demonstrated a mass in 50% cases. Definitive histology reported 4 adenomas, 2
carcinomas-in-situ and 9 adenocarcinomas. Median hospital stay was 13 days. There was no
operative mortality. Mean duration of follow-up was 31 months (range 7-70 months). The
procedure appears curative for adenomas and in-situ carcinoma. Overall 3 year actuarial
survival for ampullary tumours is 65% while that for moderately differentiated carcinomas is
50%.
Pre-operative investigations provide inadequate histological information. Wide local excision is
a safe operation with low morbidity and good survival in carefully selected cases. However, the
role of local excision for carcinoma appears to be palliative rather than curative.
INTRODUCTION
Ampullary tumours are uncommon tumours
arising fromthe surface ofthepapillaofVater or
from the inner epithelial lining of the ampulla
itself.'CarcinomasoftheampullaofVateraccount
for approximately 6% of all periampullary
tumours.3 Villous adenomas ofthe ampulla have
a reported incidence of 0.04-0.12 per cent.3 The
reported incidence of malignancy varies widely
butseems tobearound25percent.4'5 Itisdifficult
to get an accurate preoperative histological
gradingofthetumour.",5Villous adenomasofthe
ampullaareconsideredpremalignant andthere is
controversy regarding optimum surgical
management."4 There are two main surgical
options - local, transduodenal excision of the
tumour (ampullectomy) or pancreaticoduoden-
ectomy. This study is anevaluation of 15patients
with ampullary tumours who underwent local
excision.
PATIENTS AND METHODS
Between April, 1995 and June, 2000 fifteen
patients with tumours of the ampulla of Vater
underwent transduodenal excision (TDE). The
indications for TDE were either operative
feasibility (i.e. tumour small enough
macroscopicallytoallowconfidentcompletelocal
excision) or significant associated co-morbidity
preventing apancreaticoduodenectomy. Patients
were identified from the hepatobiliary database
and the records were reviewed for clinical
presentation,preoperativeinvestigations, surgery,
immediate postoperative complications,
pathological findings, hospital stay and follow-
up.
Thehistologyreports werereviewedwithregards
to tumoursize, resectionmargins,pancreatic and
lymphovascular invasion, the T stage (UICC)
andtumourdifferentiation. Survivalanalysis was
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donebythe method ofKaplan-Meier. Difference
in survival between subsets was comparedby the
log-rank test.
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Fig 1. Stay sutures are inserted around the tumour as
markers for wide diathermy excision (a) prior to
excision of the papilla of Vater, encompassing
part ofbiliary and pancreatic ducts and posterior
duodenal wall (b).
Surgical procedure
Theprocedureinvolves atransduodenalapproach
viaalongitudinalduodenotomy. Fourstaysutures
are inserted around the tumour as markers
(figure la). A wide diathermy excision is
performed around the stay sutures to ensure a
clear margin. Excision involves a wide resection
ofthe papilla ofVater, encompassing part ofthe
biliary and pancreatic ducts and a part of the
posteriorduodenalwall (figure Ib). Thebileduct
and the pancreatic duct are sutured together to
form a common septum and both ducts are then
re-implanted(figures2aandb).Theduodenotomy
isclosed. Cholecystectomy isroutinelyperformed
to avoid cholecystitis secondary to duodeno-
biliaryreflux. Afeedingjejunostomy isroutinely
insertedtoallowenteralnutritionintheimmediate
post-operative period.
C D
Fig 2. Bile duct and pancreatic duct sutured together to
formacommonSeptum(c)priortore-implantation
in the duodenum (d).
RESULTS
Clinical Features
Theclinicalpresentation,preoperativediagnosis,
final pathological diagnosis, complications and
outcome are summarized in Table 1. There were
12 males (80%) and 3 females (20%) with a
median age of 68 years (range, 54 to 78 years).
Ten patients (66%) hadjaundice (ofthese 2 also
had rigors). Seven patients (46%) complained of
abdominalpain (ofthese 1 alsohadbackache). In
two patients the ampullary tumour was an
incidental finding. The first of these (no. 2) was
a 78 year old woman, found to have abnormal
liverfunctiontestsduringinvestigationofcardiac
disease. The otherwas a70yearoldman (no. 13)
who was initially admitted with fractured ribs
and on examination was also found to have
jaundice. One patient presented with
haematemesis. Onepatient(no. 14) wasoperated
onurgentlyasshewasthoughttohaveunresolving
jaundiceduetobileductstones. Otherpresenting
features were anorexia (n=4), weight loss (n=4),
lethargy (n=3), nausea (n=3), anaemia (n=l) and
steatorrhoea (n=l). The duration between onset
of symptoms and surgery ranged from 3 to 56
weeks.
Investigations
CTScanshowedanampullary massin6(50%)of
the 12casesinwhichitwasperformed.Ultrasound
Scan was performed in 9 patients and revealed a
dilated biliary duct system in 8. Preoperative
endoscopywasperformedin 13casesandbiopsies
were taken in 12 patients. Endoscopy was not
done in 2 cases - 1 due to delay in surgery while
waiting for ERCP and in 1 case jaundice was
thought to be secondary to bile duct stones and
the patient underwent intraoperative
cholangiogram and duct exploration. Three
patients were stented preoperatively at ERCP.
Complications and hospital stay
In the immediate post-operative period, one
patient developed a subphrenic abscess which
was drainedpercutaneously and one developed a
wound infection. There was no postoperative
hospital mortality. Median hospital stay was 13
days (range 7-49 days). In the long term, two
patients developed incisional herniae and one
developed a metastatic skin nodule with no
evidence of recurrence intra-abdominally, 34
months after primary excision of ampullary
carcinoma-in-situ(no.6).Thisnodulewasexcised
and the patient is alive and well at 41 months.
i The Ulster Medical Society, 2002.
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TABLE
Demography, Clinicalfeatures, Pathology and outcome
Patient Age, Clinical Preoperative Final Diagnosis Complications Follow-up in
No. y/sex Features Diagnosis Tstage! months/results
Differentiation
J, Rigors,
Lethargy
Incidental
P, N, V, W
Lethargy,
Anaemia
J, P, W, N, V
J, N
J
Haematemesis
Adenoma,
Severe Dysp.
Adenoma,
Severe Dysp
Adenoma
Adenoma,
Severe Dysp.
Inadequate
Adenoma,
Severe Dysp.
Adenoma
Adenoma
Mild Dysp.
P,J
AdenoCa
T2/Moderate
Adenoma,
Severe Dysp.
Adenoma,
Severe Dysp.
AdenoCa
T2/Poor
AdenoCa
TI/Poor
Ca-in-situ
AdenoCa
T2/Moderate
Adenoma,
Mild Dysp.
AdenoCa
T2/Moderate
None
None
None
None
None
None
Sub-phrenic
abscess
None
Wound
infection
17 months,
Disease free
70 months,
Disease free
15 months,
Disease free
8 months,
Disease free
10 months,
Died of local
recurrence
41 months,
Scar nodule
56 months
Disease free
29 months,
Disease free
43 months,
Disease free
10 71/M
11 61/M
12 62/M
J,W,
Steatorrhoea,
P, Rigor with
temperature
J
Normal
Adenoma, Mild
Dysp.
Adenoca
AdenoCa
T2/Poor
Adenoma,
Moderate Dysp.
AdenoCa
T2/Moderate
None
None
None
10 months,
Disease free
52 months,
Disease free
30 months,
Died of local
recurrence,
liver involved
13 70/M
14 70/F
15 66/M
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1 72/M
2 78/M
3 77/M
4 69/F
5 65/M
6 68/F
7 66/M
8 64/M
9 54/M
Adenoma Incidental, J
J, P, N, V
J, P, W
Ca-in-Situ None
None
None
AdenoCa
T2/Poor
AdenoCa
T2/Moderate
53 months,
Disease free
7 months,
Died of local
recurrence
30 months,
Died of local
recurrence
(J-jaundice, P-pain, N-nausea, V-vomiting, W-weight loss, Dysp.-Aysplasia, Ca.Carcinoma)
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Histo-pathology
Preoperative endoscopic biopsy was accurate in
only 5 patients (41%) of whom 4 had adenomas
and 1 had an adenocarcinoma. Multiple biopsies
wereroutinelyundertaken atendoscopy. Amongst
the remainder, preoperative biopsy revealed a
villous adenoma with severe dysplasia in 5
patients ofwhom2 eventually hadcarcinoma-in-
situ, 2 had a moderately differentiated
adenocarcinomaand 1 had apoorlydifferentiated
adenocarcinoma. One preoperative biopsy was
insufficient and 1 was normal. Both turned out to
bepoorlydifferentiatedadenocarcinomas. Intotal,
4patientshadadenomas, 2hadcarcinoma-in-situ
and 9 had adenocarcinoma, of which 5 were
moderately differentiated and 4 poorly
differentiated. Of the 9 adenocarcinomas 1 was
in stage TI and 8 were T2. Frozen section biopsy
performed in one patient (9) was reported as
benign though definitive histology revealed
moderately differentiated adenocarcinoma.
Resectionmargins wereclearin 14patients. A re-
laparotomy could not be undertaken in the one
patient with involved resection margins due to
significant associated co-morbidity. There was
no pancreatic invasion, though lympho-vascular
invasion was found in 3 cases. Mean tumour
diameter was 2.5 cms (range, 1.5 to 4.2 cms).
Mean duration of follow-up was 31.4 months
(range, 7 to 70 months).
Outcome
The longest survival in this study was 70 months
(no. 2) with a total of 4 patients alive after 50
months, 1 with a diagnosis of moderately
differentiatedadenocarcinoma, 1 withcarcinoma-
in-situ and 2 with dysplastic adenomas. Four
patients (26 percent) died in this study. All the
patients died of local recurrence. Two of these
had T2, moderately differentiated tumours, and
the other 2 had poorly differentiated tumours in
stage TI and T2. Survival was worst inthepoorly
differentiated group - 1 patient who also had
involved resection margins surviving 7 months
and another 10 months while both the patients
with moderately differentiated carcinomas
survived 30 months. Of the 3 patients with
lymphovascular invasion 2 had poorly
differentiated and 1 had a moderately
differentiated carcinoma. The latter is alive at 43
months while of the patients with poorly
differentiated carcinoma with lymphovascular
invasion 1 is alive at 10months andthe otherdied
at 7 months.
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Fig 3. Overall actuarial survival (Kaplan Meier) 1
yearsurvival was 86% while 3 and5 yearsurvival
was 65%.
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Fig 4. Survival by degree of differentiation.
The overall 1 year actuarial survival (Kaplan-
Meier) forampullary tumours (figure3) was 86%
(95% confidence interval 55-96%) while the 3
and 5 year survival was 65% (95% confidence
interval 29-86%). Three year survival for
moderately differentiated cancers (figure 4) was
50% (95% confidence interval 6-84%) while the
longest survival for patients with poorly
differentiated carcinoma was only 10 months in
this study. Because oftherelatively shortfollow-
up and small series it is difficult to accurately
interpret long-term survival at this point.
DISCUSSION
On the basis ofautopsy investigations, the rate of
neoplastic lesions ofthe ampulla ranges between
0.063-0.21 %.5 Halsted first reported
The Ulster Medical Society, 2002.
Benign and in-situ carcinomas
Moderately differentiated
Poorly differentiated
P<O.05(log-rank test)
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transduodenal excision of an ampullary mass in
1899.6 In 1935 A. 0. Whipple reported a 2-stage
resection of ampullary carcinoma.7
Although the ampulla is easily accessible by
endoscopy there is a high reported incidence of
false negative results for biopsy of carcinoma,
ranging from 25-60%.l,5,89, 10,11 The results in
this study are similar, withafalsenegativerateof
59%. CT scan detection ofa lesion is considered
even less sensitive with a reported figure of
around 20% in some studies.1 Endoscopic
ultrasonography aided diagnosis and staging has
been widely recommended. 12,13,14 However,
Cahen et al reported an accuracy of only 44 per
cent with endoscopic ultrasonography assisted
stagingandafalsepositiveoutcomeformetastatic
lymph nodes in 31% oftheir cases.3 Endoscopic
ultrasonography was not available forthis study.
Per-operative frozen sections are unreliable in
excluding malignancy and can also give false
positive results.5 15 It seems nearly impossible to
exclude,withcertainty,thepresenceofcarcinoma
in an adenoma without complete excision.5
While TDE is now accepted as the procedure of
choice for benign adenomas, pancreatico-
dudenectomy is the commonly recommended
surgery for ampullary cancer.'0 There have been
recommendations for radical surgery even for
benignlesionswithsomeauthorscitingproblems
like ahigh incidence ofmalignancy, difficulty in
accurate pre-operative confirmation, tendency
for tumours to recur and concerns regarding the
oncological adequacy of local resection for
ampullarycancers.8'9 16 3-year survival around
55 to60percentand5-yearsurvival around 35 to
55 per cent has been reported after
pancreaticoduodenectomy.171-9 Beger et al
reported 3- and 5-year survival rates of72% and
52%respectively withROresections afterradical
surgery, but RO resection was possible in only
62% ofthemalignantcases intheirstudy, with an
intra-abdominal complication rate of 25%. The
present study with overall actuarial 3 and 5 year
survivalprojections of65% wouldtend tofavour
the less radical approach.
Some reports also suggest that local resection is
oncologicallyacceptablewithcomparableresults
and low morbidity in selective cases.3 5' ' Tarazi
etalreported a 2 year survival of55 per cent and
a 5-year survival of 41 per cent following TDE
forcarcinomas.20 Newman and Pittamreported a
5 year survival of 41 per cent and a surviving
patient 15 years after TDE for ampullary
carcinoma.20 Wise et al have reported a 3 year
survival at 50 percent and 5 year survival at 37.5
per cent.22 Knox and Kingston have reported a
better 1, 2, 3 and 5 year survivals following TDE
compared to radical procedures.23 Robertson and
Imrie reported a median survival of 57 months
with44%five-yearactuarialsurvival,afterTDE.24
Fifty percent of their survivors developed
recurrentdiseasewhiletherewasa25%incidence
ofpost-operative deaths. Talamini etalin alarge
study of 28 years experience from the John
Hopkins Institution reported an overall mortality
of 3.8% after radical resection with no deaths in
the last 5 years in consecutive 45 patients.25
Morbidity in the latter part of their study had
reduced to 38%. Five-year survival was 38% and
they believed avoidance oftransfusion improved
the prognosis. Various studies have proposed
thatTDEisjustifiablewhentheampullarytumour
is pTl(UICC-staging) and graded GI or G2
(highly or moderately differentiated) with no
lymphatic infiltration and complete resection
(RO).5'26 The present study would tend to
corroborate these suggestions. Unfortunately
accurate TNM staging pre- or peroperatively is
not feasible.
Howe et al, in a prospective study of the
correlationbetweenclinicopathological variables
and survival of 123 patients presenting with
ampullary carcinomas, found negative margins
and negative nodes as independent predictors of
improved survival.2 Lymphatic drainage of
tumoursoftheampullaisdistinctfrompancreatic
tumours in that, even in advanced cases, they
seem to involve only a local group of lymph
nodes near the ampulla, yielding a superior
prognosis if the infiltration does not involve
pancreatic tissue.5'27 Pancreatic involvement is
closely related to extensive nodal involvement
and ampullary cancers invading the pancreatic
parenchymamay actmorelikepancreaticcancers
resulting in a poor prognosis.5'27 In our study
there wasnopancreatic involvementinanyofthe
cases and resection margins appeared clear in all
but one case. Neither size nor duration of
symptomshavebeenreportedtoaccuratelypredict
the presence of malignancy.10 Interestingly, in
thepresentstudy all 10patients withjaundicehad
carcinomaorcarcinoma-in-situ whilenoneofthe
patients with villous adenomahadjaundice. This
would be in keeping with some reports which
suggest that malignant lesions tend to present
C The Ulster Medical Society, 2002.
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withjaundice while benign lesions do not."9' 10It
wouldbe interesting to see from larger studies in
thefutureifelevatedbilirubincouldbeutilisedas
a guide to the general decision making regarding
the appropriate procedure and also as apredictor
of survival in tumours of the ampulla.
In conclusion, our study suggests that obtaining
an exact preoperative diagnosis for ampullary
tumours is very difficult. None of the existing
investigative tools seem to be entirely
confirmative aboutthetruehistological natureof
the tumour and the extent of the disease.
Transduodenal excision of ampullary tumours
seemscurativeforbenigntumours andforin-situ
cancers. It is a low risk alternative for patients
withcarcinomawhoarepoorsurgicalrisksdueto
ageorco-morbidity. Oncologically,localexcision
ofcarcinomaappearstobeapalliativeratherthan
curative procedure.
REFERENCES
1. PosnerS,CollettiL, KnotJ, MulhollandM, Eckhauser
F. Safety and long-term efficacy of transduodenal
excision for tumors of the ampulla of Vater. Surgery
2000; 128(4): 694-701.
2. Howe J R, Klimstra D S, Moccia R D, Conlon K C,
Brennan M F. Factors predictive of survival in
ampullary carcinoma. Ann Surg 1998; 228(1): 87-94.
3. Cahen D L, Fockens P, de Wit L T, Offerhaus G J A,
Obertop H, Gourna D J. Local resection or
pancreaticoduodenectomy for villous adenoma ofthe
ampulla of Vater diagnosed before operation. Br J
Surg 1997; 84(7): 948-51.
4. Treitschke F, Beger H G. Local resection of benign
periampullary tumors. Ann Oncol 1999; 10(Suppl4):
212-4.
5. BegerH G, Treitschke F, GansaugeF, HaradaN, Hiki
N, Mattfeldt T. Tumor of the Ampulla of Vater
experience with local or radical resection in 171
consecutivelytreatedpatients. ArchSurg 1999; 134(5):
526-32.
6. Halsted W S. Contributions to the surgery of the bile
duct passages, especially of the common bile duct.
Boston Med Surg J 1899; 141: 645-54.
7. Whipple A, Parsons W, Mullins C. Treatment of
carcinoma ofampulla of Vater. Ann Surg 1935; 102:
763-79.
8. Chappuis C, Divincenti F C, Cohn I. Villous tumours
of the duodenum. Ann Surg 1989; 209(5): 593-9.
9. Ryan D P, Schapiro R H, Warshaw A L. Villous
tumors ofthe duodenum. Ann Surg 1985; 203: 301-6.
10. Rattner D W, Fernandez-del Castillo C, Brugge W R,
Warshaw A L. Defining thecriteriaforlocal resection
of ampuilary neoplasms. Arch Surg 1996; 131(4):
366-71.
11. Yamaguchi K, Enjoji M, Kitamura K. Endoscopic
biopsy hadlimitedaccuracy indiagnosis ofampullary
tumors. Gastrointest Endosc 1990; 36(6): 588-92.
12. Tio T L, Sie L H, Verbeek P C M, De Wit L T, Tytgat
G N J. Endosonography in diagnosing and staging
duodenal villous adenoma. Gut 1992; 33(4): 567-8.
13. Yasuda K, Mukai H, Cho E, Nakajima M, Kawai K.
Theuseofendoscopicultrasonography inthediagnosis
and staging of carcinoma of the papilla of Vater.
Endoscopy 1988; 20(Suppl 1): 218-22.
14. Rosch T, Braig C, Gain T, Feuerbach S, Stewart J R,
Schusdziorro V, et al. Staging of pancreatic and
ampullarycarcinomabyendoscopic ultrasonography.
Comparisonwithconventional sonography, computed
tomography, and angiography. Gastroenterology
1992; 10(1): 188-99.
15. Asbun HJ, Rossi RL, MunsonJL. Local resection for
ampullary tumors. Is there a place for it? Arch Surg
1993; 128(5): 515-20.
16. Chareton B, Coiffic J, Landen S, Bardaxoglou E,
Campion J P, Launois B. Diagnosis and therapy for
ampullary tumors: 63 cases. World J Surg 1996;
20(6): 707-12.
17. Harada N, Treitschke F, Imaizumi T, Beger H G.
Pancreatic invasion is a prognostic indicator after
radical resection for carcinoma of the ampulla of
Vater. J Hepato-Biliary-Pancreatic Surg 1997; 4:
215-19.
18. Hanyu F, Imaizumi T, Nakamura M, Yoshikawa T.
Proposed definition of early cancer of the papilla of
Vater. J Biliary Tract Pancreas 1984; 5: 847-52.
19. WillettC G,Warshaw AL, Convery K,Compton C C.
Patterns offailure afterpancreaticoduodenectomy for
ampullary carcinoma. Surg Gynecol Obstet 1993;
176(1): 33-8.
20. Tarazi R Y, Hermann R E, Vogt D P, Hoerr S 0,
Esselstyn C B, Coperman A M, et al. Results of
surgical treatment of periampullary tumours: a 35
years experience. Surgery 1986; 100: 716-23.
21. Newman R J, Pittam M R. Local excision in the
treatment of carcinoma of the ampulla of Vater. J R
Coll Surg Edinb 1982; 27(3):154-7.
22. Wise L, Pizzimbono C, Dehrier L P. Periampullary
cancer. A clinico-pathologic study of62 patients. Am
JSurg 1976; 131(2): 141-8.
23. Knox R A, Kingston R D. Carcinoma of the ampulla
of Vater. Br J Surg 1986; 73(1): 72-3.
24. Robertson JF, ImrieCW. Localexcisionofampullary
carcinoma. Acta Chir Scand 1986; 152: 537-9.
C The Ulster Medical Society, 2002.Transduodenal excision ofampullary tumours 127
25. Talamini M A, Moesinger R C, Pitt H A, Sohn T A,
Hruban R H, Lillemoe K D. Adenocarcinoma of the
ampulla of Vater. A 28-year experience. Ann Surg
1997; 225: 590-9.
26. Klein P, Reingruber B, Kastl S, Dworak 0,
Hohenberger W. Is local excision of pTl -ampullary
Carcinomasjustified? EurJ Surg Oncol 1996; 22(4):
366-71.
27. ShiraiY,OhtaniT,TsukadaK,HatakeyamaK. Patterns
of lymphatic spread of carcinoma of the ampulla of
Vater. Br J Surg 1997; 84(7): 1012-6.
C The Ulster Medical Society, 2002.